• Home
  • News
  • Coins2Day 500
  • Tech
  • Finance
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Coronavirus

A new coronavirus test in Singapore is providing clues about how the outbreak spreads

By
Elffie Chew
Elffie Chew
and
Bloomberg
Bloomberg
Down Arrow Button Icon
By
Elffie Chew
Elffie Chew
and
Bloomberg
Bloomberg
Down Arrow Button Icon
February 26, 2020, 1:40 AM ET

A medical research team in Singapore has managed to establish links between cases in the city-state using a new testing method.

Using a serological test developed by researchers from the Duke-NUS Medical School, the team was able to confirm that two individuals had earlier been infected with the coronavirus, also known as COVID-19, the Ministry of Health announced Tuesday. Serological tests identify antibodies in blood samples, which the immune system produces in response to an infection.

The researchers had earlier successfully cultured the COVID-19 virus in less than a week after Singapore confirmed its first case, the ministry said. Using the virus and genetic material derived from the virus, the research team then developed several specific laboratory tests to detect the virus-specific antibodies for contact tracing and other applications, according to the statement.

“Hopefully, some serological tests will become more widely available from commercial sources soon,” said Peter Collignon, a professor of clinical medicine at the Australian National University Medical School in Canberra, who advises the Australian government on infection control. “After serological tests — or serosurveys — have been done, we will know much more about spread of the virus, and what the true mortality rate is.”

The two individuals identified in Singapore were linked to local church clusters. The city-state has 91 confirmed cases of coronavirus, and virus recoveries –currently at 58 — are outpacing new cases.

Deputy Prime Minister Heng Swee Keat said in a Facebook post Wednesday the country has invested significantly in building up its research and development eco-system, especially in health and bio-medical sciences, over the years. “Strong R&D capabilities are essential to mounting an effective response to the outbreak so that we can respond better with facts and an evidence-based approach,” he said.

More must-read stories from Coins2Day:

—Europe’s first big Covid-19 outbreak roils global markets
—Billionaires are donating to fight China’s coronavirus
—94% of Coins2Day 1000 are seeing coronavirus supply chain disruptions
—Coronavirus misinformation is fueled by government mistrust
—Coronavirus may be the straw that breaks the back of oil fracking

Subscribe to Coins2Day’s forthcoming Eastworld newsletter for expert insight on what’s dominating business in Asia.

About the Authors
By Elffie Chew
See full bioRight Arrow Button Icon
By Bloomberg
See full bioRight Arrow Button Icon
Rankings
  • 100 Best Companies
  • Coins2Day 500
  • Global 500
  • Coins2Day 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Coins2Day Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Coins2Day Brand Studio
  • Coins2Day Analytics
  • Coins2Day Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Coins2Day
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

© 2025 Coins2Day Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Coins2Day Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.